Innovassynth Technologies India Ltd vs Sudarshan Pharma Industries Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Jun 10, 2026

Key Highlights

The Latest Trading Price of Innovassynth Technologies (India) Ltd is ₹ 108.28 as of 09 Jun 15:30 . The P/E Ratio of Innovassynth Technologies (India) Ltd changed from 38.2 on March 2022 to 0 on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Sudarshan Pharma Industries Ltd changed from 19.1 on March 2023 to 0 on March 2021 . This represents a CAGR of -100.00% over 4 years The Market Cap of Innovassynth Technologies (India) Ltd changed from ₹ 46.37 crore on March 2022 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Sudarshan Pharma Industries Ltd changed from ₹ 134.29 crore on March 2023 to ₹ 0 crore on March 2021 . This represents a CAGR of -100.00% over 4 years The revenue of Innovassynth Technologies (India) Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Sudarshan Pharma Industries Ltd for the Mar '26 is ₹ 225.05 crore as compare to the Dec '25 revenue of ₹ 169.52 crore. This represent the growth of 32.76% The ebitda of Innovassynth Technologies (India) Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Sudarshan Pharma Industries Ltd for the Mar '26 is ₹ 24.32 crore as compare to the Dec '25 ebitda of ₹ 12.39 crore. This represent the growth of 96.29% The net profit of Innovassynth Technologies (India) Ltd changed from ₹ -5.86 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Sudarshan Pharma Industries Ltd changed from ₹ -1.21 crore to ₹ 11.39 crore over 8 quarters. This represents a CAGR of NaN% The Dividend Payout of Innovassynth Technologies (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Sudarshan Pharma Industries Ltd changed from 10.26 % on March 2023 to 0 % on March 2025 . This represents a CAGR of -100.00% over 3 years .

About Innovassynth Technologies (India) Ltd

Innovassynth Investments Limited (IIL) was incorporated on February 15, 2008 as an Investment Company.
IIL obtained the Certificate of Commencement of Business on March 4, 2008.
Earlier, the Company was engaged in the business of customs synthesis, contract research & manufacturing of specialty chemicals, toll manufacture of chemicals and similar businesses. The Company was promoted by Futura Polyesters Limited (FPL) with an initial paid up capital of Rs. 5 lakhs.
The main purpose for forming IIL was to take over or acquire the equity shares of Innovassynth Technologies (India) Limited (ITIL), an associate company, from FPL under a Scheme of Arrangement to be entered into by FPL and IIL with its shareholders.
The Company is in the investment business and the Company holds 31.79% in Innovassynth Technologies (India) Limited.

About Sudarshan Pharma Industries Ltd

Sudarshan Pharma Industries Limited was initially incorporated as a Private Limited Company with the name 'Sudarshan Specialty Chemsolve Private Limited' on July 23, 2008 with the Registrar of Companies, Mumbai.
Later in year 2016. name of the Company changed from 'Sudarshan Specialty Chemsolve Private Limited' to 'Sudarshan Pharma Industries Private Limited' on 17 December 2016.
Thereafter, the Company converted into a Public Limited and name of the Company was changed to 'Sudarshan Pharma Industries Limited' on January 5, 2017. The Company was promoted by Mr. Hemal V. Mehta & Mr. Sachin V. Mehta, who have a combined experience of over 25 years in the Special Chemical, Bulk drug and Pharmaceutical Industry.
At present, Company perates in pharmaceutical and chemical industries, focusing on specialty chemicals and intermediates used in pharmaceuticals, paints, food products, and adhesives.

FAQs for the comparison of Innovassynth Technologies (India) Ltd and Sudarshan Pharma Industries Ltd

Which company has a larger market capitalization, Innovassynth Technologies (India) Ltd or Sudarshan Pharma Industries Ltd?

Market cap of Innovassynth Technologies (India) Ltd is 1,005 Cr while Market cap of Sudarshan Pharma Industries Ltd is 842 Cr

What are the key factors driving the stock performance of Innovassynth Technologies (India) Ltd and Sudarshan Pharma Industries Ltd?

The stock performance of Innovassynth Technologies (India) Ltd and Sudarshan Pharma Industries Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Innovassynth Technologies (India) Ltd and Sudarshan Pharma Industries Ltd?

As of June 10, 2026, the Innovassynth Technologies (India) Ltd stock price is INR ₹108.28. On the other hand, Sudarshan Pharma Industries Ltd stock price is INR ₹35.0.

How do dividend payouts of Innovassynth Technologies (India) Ltd and Sudarshan Pharma Industries Ltd compare?

To compare the dividend payouts of Innovassynth Technologies (India) Ltd and Sudarshan Pharma Industries Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.